Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Aug;74(8):1095–1099. doi: 10.1136/jnnp.74.8.1095

The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists

M Holtkamp 1, F Masuhr 1, L Harms 1, K Einhaupl 1, H Meierkord 1, K Buchheim 1
PMCID: PMC1738579  PMID: 12876241

Abstract

Objective: To survey the current clinical treatment of refractory status epilepticus and to identify steps in its management which may need further investigation.

Methods: Epileptologists and critical care neurologists were surveyed using a standardised postal questionnaire.

Results: Sixty three of 91 participants (69%) returned the questionnaires. Two thirds of the respondents applied another non-anaesthetising anticonvulsant after failure of first line drugs. General anaesthesia for ongoing complex partial status epilepticus (CPSE) was part of the therapeutic regimen of 75% of the interviewees. A non-barbiturate as general anaesthetic of first choice was used by 42%. Up to 70% titrated the anaesthetic to achieve a burst suppression pattern in the electroencephalogram, indicating deep sedation, and 94% reduce anaesthesia within 48 hours.

Conclusions: The management of refractory status epilepticus is heterogeneous in many aspects, even among clinicians who are most familiar with this severe condition. Randomised trials are needed to compare the efficacy, side effects, optimal duration, and depth of general anaesthesia.

Full Text

The Full Text of this article is available as a PDF (232.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aminoff M. J. Do nonconvulsive seizures damage the brain?--No. Arch Neurol. 1998 Jan;55(1):119–120. doi: 10.1001/archneur.55.1.119. [DOI] [PubMed] [Google Scholar]
  2. Aminoff M. J., Simon R. P. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980 Nov;69(5):657–666. doi: 10.1016/0002-9343(80)90415-5. [DOI] [PubMed] [Google Scholar]
  3. Borbas C., Morris N., McLaughlin B., Asinger R., Gobel F. The role of clinical opinion leaders in guideline implementation and quality improvement. Chest. 2000 Aug;118(2 Suppl):24S–32S. doi: 10.1378/chest.118.2_suppl.24s. [DOI] [PubMed] [Google Scholar]
  4. Cascino G. D., Hesdorffer D., Logroscino G., Hauser W. A. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia. 1998 Aug;39(8):829–832. doi: 10.1111/j.1528-1157.1998.tb01176.x. [DOI] [PubMed] [Google Scholar]
  5. Claassen J., Hirsch L. J., Emerson R. G., Bates J. E., Thompson T. B., Mayer S. A. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001 Sep 25;57(6):1036–1042. doi: 10.1212/wnl.57.6.1036. [DOI] [PubMed] [Google Scholar]
  6. Claassen Jan, Hirsch Lawrence J., Emerson Ronald G., Mayer Stephan A. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002 Feb;43(2):146–153. doi: 10.1046/j.1528-1157.2002.28501.x. [DOI] [PubMed] [Google Scholar]
  7. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000 Sep 12;55(5):693–697. doi: 10.1212/wnl.55.5.693. [DOI] [PubMed] [Google Scholar]
  8. DeLorenzo R. J., Hauser W. A., Towne A. R., Boggs J. G., Pellock J. M., Penberthy L., Garnett L., Fortner C. A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996 Apr;46(4):1029–1035. doi: 10.1212/wnl.46.4.1029. [DOI] [PubMed] [Google Scholar]
  9. Engel J., Jr, Ludwig B. I., Fetell M. Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology. 1978 Sep;28(9 Pt 1):863–869. doi: 10.1212/wnl.28.9.863. [DOI] [PubMed] [Google Scholar]
  10. Hesdorffer D. C., Logroscino G., Cascino G., Annegers J. F., Hauser W. A. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology. 1998 Mar;50(3):735–741. doi: 10.1212/wnl.50.3.735. [DOI] [PubMed] [Google Scholar]
  11. Hesdorffer D. C., Logroscino G., Cascino G., Annegers J. F., Hauser W. A. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol. 1998 Dec;44(6):908–912. doi: 10.1002/ana.410440609. [DOI] [PubMed] [Google Scholar]
  12. Holtkamp M., Tong X., Walker M. C. Propofol in subanesthetic doses terminates status epilepticus in a rodent model. Ann Neurol. 2001 Feb;49(2):260–263. [PubMed] [Google Scholar]
  13. Hosford D. A. Animal models of nonconvulsive status epilepticus. J Clin Neurophysiol. 1999 Jul;16(4):306–353. doi: 10.1097/00004691-199907000-00002. [DOI] [PubMed] [Google Scholar]
  14. Kaplan P. W. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol. 1999 Jul;16(4):341–353. doi: 10.1097/00004691-199907000-00006. [DOI] [PubMed] [Google Scholar]
  15. Knake S., Rosenow F., Vescovi M., Oertel W. H., Mueller H. H., Wirbatz A., Katsarou N., Hamer H. M., Status Epilepticus Study Group Hessen (SESGH) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001 Jun;42(6):714–718. doi: 10.1046/j.1528-1157.2001.01101.x. [DOI] [PubMed] [Google Scholar]
  16. Krishnamurthy K. B., Drislane F. W. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999 Jun;40(6):759–762. doi: 10.1111/j.1528-1157.1999.tb00775.x. [DOI] [PubMed] [Google Scholar]
  17. Krishnamurthy K. B., Drislane F. W. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia. 1996 Sep;37(9):863–867. doi: 10.1111/j.1528-1157.1996.tb00039.x. [DOI] [PubMed] [Google Scholar]
  18. Krumholz A., Sung G. Y., Fisher R. S., Barry E., Bergey G. K., Grattan L. M. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. 1995 Aug;45(8):1499–1504. doi: 10.1212/wnl.45.8.1499. [DOI] [PubMed] [Google Scholar]
  19. Logroscino G., Hesdorffer D. C., Cascino G., Annegers J. F., Hauser W. A. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997 Dec;38(12):1344–1349. doi: 10.1111/j.1528-1157.1997.tb00073.x. [DOI] [PubMed] [Google Scholar]
  20. Lowenstein D. H., Aminoff M. J., Simon R. P. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology. 1988 Mar;38(3):395–400. doi: 10.1212/wnl.38.3.395. [DOI] [PubMed] [Google Scholar]
  21. Mayer Stephan A., Claassen Jan, Lokin Johnny, Mendelsohn Felicia, Dennis Lyle J., Fitzsimmons Brian-Fred. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002 Feb;59(2):205–210. doi: 10.1001/archneur.59.2.205. [DOI] [PubMed] [Google Scholar]
  22. Meldrum B. S., Brierley J. B. Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973 Jan;28(1):10–17. doi: 10.1001/archneur.1973.00490190028002. [DOI] [PubMed] [Google Scholar]
  23. Meldrum B. S., Horton R. W. Physiology of status epilepticus in primates. Arch Neurol. 1973 Jan;28(1):1–9. doi: 10.1001/archneur.1973.00490190019001. [DOI] [PubMed] [Google Scholar]
  24. Rashkin M. C., Youngs C., Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology. 1987 Mar;37(3):500–503. doi: 10.1212/wnl.37.3.500. [DOI] [PubMed] [Google Scholar]
  25. Shorvon S. Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):125–134. doi: 10.1136/jnnp.56.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sneyd J. R. Propofol and epilepsy. Br J Anaesth. 1999 Feb;82(2):168–169. doi: 10.1093/bja/82.2.168. [DOI] [PubMed] [Google Scholar]
  27. Stecker M. M., Kramer T. H., Raps E. C., O'Meeghan R., Dulaney E., Skaar D. J. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. 1998 Jan;39(1):18–26. doi: 10.1111/j.1528-1157.1998.tb01269.x. [DOI] [PubMed] [Google Scholar]
  28. Treiman D. M., Meyers P. D., Walton N. Y., Collins J. F., Colling C., Rowan A. J., Handforth A., Faught E., Calabrese V. P., Uthman B. M. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998 Sep 17;339(12):792–798. doi: 10.1056/NEJM199809173391202. [DOI] [PubMed] [Google Scholar]
  29. Walker M. C., Smith S. J., Shorvon S. D. The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia. 1995 Feb;50(2):130–135. doi: 10.1111/j.1365-2044.1995.tb15095.x. [DOI] [PubMed] [Google Scholar]
  30. Wasterlain C. G., Fujikawa D. G., Penix L., Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 1993;34 (Suppl 1):S37–S53. doi: 10.1111/j.1528-1157.1993.tb05905.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES